INDICATIONS AND USAGE

SPRYCEL® (dasatinib) is a prescription medicine used to treat:

  • adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase
  • adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including Gleevec® (imatinib mesylate)
  • adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment
  • children 1 year of age and older with Ph+ CML in chronic phase
  • children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy

Close

SPRYCEL® (dasatinib) 100-mg tablets SPRYCEL® (dasatinib) 100-mg tablets
MENU
SPRYCEL Assist program
Image of a man and woman walking

I've Got Knowledge

How is Ph+ CML monitored?

Your healthcare provider may perform tests of your blood and bone marrow Bone marrow: the soft tissue inside bones that produces blood cells  at various time points after starting treatment. These tests may be scheduled at 3 months, 6 months, 12 months, and beyond. Your testing schedule (how often you will have tests performed in the future) will be determined by your healthcare provider.

What Tests Are Used To Evaluate and Monitor Ph+ CML?

Test Type What the Test Measures Sample Required for Test
Hematological Hematological: test that can detect the number of white blood cells, red blood cells, and platelets in the blood 
Complete blood count (CBC)		 White blood cells White blood cells : blood cells that help fight infections. When the level of a certain type of white blood cell is lower than normal, it is called neutropenia , red blood cells Red blood cells: blood cells that carry oxygen to all parts of the body. When red blood cell levels are lower than normal, it is called anemia  , platelets Platelets: cell fragments that help stop bleeding. When platelet levels are lower than normal, it is called thrombocytopenia  , and other blood components Blood sample
Cytogenetic
Fluorescence in situ hybridization (FISH)		 Cells carrying Philadelphia (Ph) chromosome Philadelphia (Ph) chromosome: the chromosome abnormality that causes CML; pieces from 2 different chromosomes break off and fuse together to create this new abnormal chromosome   Blood or bone marrow sample
Cytogenetic
Conventional cytogenetic		 Cells carrying Ph chromosome  Ph chromosome: the chromosome abnormality that causes CML; pieces from 2 different chromosomes break off and fuse together to create this new abnormal chromosome   Blood or bone marrow sample
Molecular*
Reverse transcriptase polymerase chain reaction (RT-PCR)		 BCR-ABL BCR-ABL: an abnormal protein that causes out-of-control production of CML cells  transcripts Blood or bone marrow sample

*The approval of SPRYCEL for Ph+ CML patients who are no longer benefiting from, or cannot tolerate, current treatment, including imatinib, was not based on results of this kind of testing.

Why Is Ongoing Testing and Monitoring Important?

Ongoing testing and monitoring is very important to help you and your doctor understand if your Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML) is being controlled appropriately over the long term. The goal of testing is to determine if your blood counts are improving and the number of leukemia cells is decreasing. These tests can also tell your doctor whether the disease may be resistant to your medicine.

A complete cytogenetic response (CCyR) is an important treatment milestone that means there are no Ph+ cells detected within your blood or bone marrow sample. If you achieve and maintain a CCyR, this means your Ph+ CML is responding to your medicine. It is important to remember that achieving a CCyR does not mean that your Ph+ CML is cured, only that leukemia cells can’t be detected. It is important to continue taking your medication as directed.

If your disease is resistant to SPRYCEL and you are not able to achieve or maintain a CCyR, your doctor may decide to change your treatment.

SPRYCEL Assist program SPRYCEL Assist program
Expand

SPRYCEL® (dasatinib) SELECTED IMPORTANT
SAFETY INFORMATION FOR PATIENTS

SPRYCEL may cause serious side effects, including low blood cell counts, bleeding problems, fluid retention, heart problems, pulmonary arterial hypertension, severe skin reactions, tumor lysis syndrome, and slowing of growth and development in children. Side effects of SPRYCEL that are considered most common in adults and children receiving SPRYCEL alone include: diarrhea, headache, skin rash, shortness of breath, tiredness, nausea, and muscle pain. Side effects of SPRYCEL that are considered most common in children receiving SPRYCEL with chemotherapy include: swelling, pain and redness of the lining of your mouth, throat, stomach and bowel (mucositis), low white blood cell counts with fever, fever, diarrhea, nausea, vomiting, muscle pain, stomach (abdominal) pain, cough, headache, rash, tiredness, constipation, abnormal heart rate, high blood pressure (hypertension), swelling, infections, low blood pressure, decreased appetite, allergic reactions, shortness of breath, nose-bleed, numbness or tingling of your hands and feet, and feeling confused or disoriented.

Please read more information about potential side effects with SPRYCEL below.

 
Expand

Important Facts About SPRYCEL® (dasatinib)

This is a summary of important information that patients need to know about SPRYCEL. Your healthcare team can work with you to help answer any questions you may have about SPRYCEL.

Keep this document in a safe place, so you can refer to it before and during treatment.

Look out for the following
icons as you read:
Talk to your
healthcare provider
Call a healthcare
provider right away
Helpful information
to remember

What is SPRYCEL?

SPRYCEL® (dasatinib) is a prescription medicine used to treat:

  • Adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP)
  • Adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including Gleevec® (imatinib mesylate)
  • Adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment
  • Children 1 year of age and older with Ph+ CML in chronic phase
  • Children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy

Example SPRYCEL tablet. Tablet is not actual size.
Tablets are white to off-white, with “BMS” appearing on one side. These letters may be followed by a number indicating the strength of the tablet, in milligrams. In addition, an identification number will be marked on the other side. Size and shape may vary by dose. Tablets are taken by mouth.

What should I discuss with my healthcare provider before starting SPRYCEL?

Talk to your healthcare provider about all of your medical conditions, including if you have any of these medical conditions:
  • problems with your
    immune system
  • heart problems, including a
    condition called congenital
    long QT syndrome
  • low potassium or low
    magnesium levels in your blood
  • lactose (milk sugar) intolerance
  • problems with your immune system
  • heart problems, including a condition called congenital long QT syndrome
  • low potassium or low magnesium levels in your blood
  • lactose (milk sugar) intolerance
Tell your healthcare provider if you are:
  • Pregnant or plan to become pregnant. SPRYCEL® (dasatinib) can harm your unborn baby. You should not become pregnant during treatment with SPRYCEL. If you are able to become pregnant, you should use effective birth control during treatment and for
    30 days after your final dose of SPRYCEL. If you become pregnant or think you may be pregnant during treatment with SPRYCEL, talk to your healthcare provider right away.
  • Breastfeeding or plan to breastfeed. It is not known if SPRYCEL passes into your breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose of SPRYCEL.
Females who are pregnant should not handle crushed or broken SPRYCEL tablets.

Tell your healthcare provider about all the medicines you take, including:

  • prescription and
    over-the-counter medicines
  • vitamins
  • herbal supplements
  • antacids

If you take an antacid medicine, take it 2 hours before or 2 hours after your dose of SPRYCEL.

 

SPRYCEL may interact with other medicines you are taking. This can change the relative effectiveness of SPRYCEL or cause unwanted side effects.

During treatment with SPRYCEL, make sure you also talk to your healthcare provider before you begin to take anything new. Your healthcare provider can help identify any potential interactions and help find alternatives.

Tell your healthcare provider about all the medicines you take, including:
  • prescription and over-the-counter
    medicines
  • vitamins
  • antacids
  • herbal supplements

If you take an antacid medicine, take it
2 hours before or 2 hours after your dose of SPRYCEL.

 

SPRYCEL may interact with other medicines you are taking. This can change the relative effectiveness of SPRYCEL or cause unwanted side effects.

During treatment with SPRYCEL, make sure you also talk to your healthcare provider before you begin to take anything new. Your healthcare provider can help identify any potential interactions and help find alternatives.

How should SPRYCEL be taken?

Take SPRYCEL exactly as your healthcare provider tells you to take it. Your healthcare provider may change your dose of SPRYCEL or temporarily stop treatment with SPRYCEL. Do not change your dose or stop taking SPRYCEL without first talking to your healthcare provider.

  • Do take SPRYCEL one (1) time a day
  • Do take SPRYCEL with or without food, either in the morning or in the evening, at the same time each day*
  • Do swallow SPRYCEL tablets whole with water
  • If your child cannot swallow tablets whole, talk with your healthcare provider

*Setting an alarm clock or calendar notification is a great way to remember to take medication.

  • Do not cut, crush, or chew the tablets
  • Do not drink grapefruit juice during treatment with SPRYCEL
  • Do not take St. John’s wort during treatment with SPRYCEL

*Setting an alarm clock or calendar notification is a great way to remember to take medication.

What if I miss a dose of SPRYCEL?

If you miss a dose of SPRYCEL, take your next scheduled dose at your regular time. Do not take two doses at the same time. Call your healthcare provider or your pharmacist if you are not sure what to do.

 

What if I take too much SPRYCEL?

Call your healthcare provider or go to the nearest hospital emergency room right away.

 

What are the possible side effects of SPRYCEL® (dasatinib)?

Serious side effects

SPRYCEL may cause serious side effects, including those listed below.

 

Call your healthcare provider right away if you have any symptoms of the side effects below, or any other concerns about these side effects:

  • Low blood cell counts: Low blood cell counts are common with SPRYCEL and can be severe, including low red blood cell counts (anemia), low white blood cell counts (neutropenia), and low platelet counts (thrombocytopenia). Your healthcare provider will do blood tests to check your blood cell counts regularly during your treatment with SPRYCEL. Call your healthcare provider right away if you have any of these symptoms during treatment with SPRYCEL:
    • fever
    • any signs of an infection
    •  
  • Bleeding problems: Bleeding problems are common with SPRYCEL. Sometimes these bleeding problems can be serious and lead to death. Call your healthcare provider right away if you have:
    • unusual bleeding or bruising of your skin
    • bright red or dark tar-like stools
    • decreased alertness, headache,
      or change in speech
  • Your body may hold too much fluid (fluid retention): Fluid retention is common with SPRYCEL and can sometimes be severe. In severe cases, fluid may build up in the lining of your lungs, the sac around your heart, or your stomach cavity. Call your healthcare provider right away if you have any of these symptoms during treatment with SPRYCEL:
    • swelling all over your body
    • weight gain
    • shortness of breath, especially if
      this happens with low levels of
      physical activity or at rest
    • dry cough
    • chest pain when taking a deep breath
  • Heart problems: SPRYCEL may cause an abnormal heart rate, heart problems, or a heart attack. Your healthcare provider will monitor the potassium and magnesium levels in your blood, and your heart function
  • Pulmonary Arterial Hypertension (PAH): SPRYCEL may cause high blood pressure in the vessels of your lungs. PAH may happen at any time during your treatment with SPRYCEL. Your healthcare provider should check your heart and lungs before and during your treatment with SPRYCEL. Call your healthcare provider right away if you have any of these symptoms:
    • shortness of breath
    • tiredness
    • swelling all over your body
      (fluid retention)
  • Severe skin reactions: SPRYCEL may cause skin reactions that can sometimes be severe. Get medical help right away if you have any of these symptoms:
    • skin reaction with fever
    • sore mouth or throat
    • blistering or peeling of your
      skin or in the mouth
  • Tumor Lysis Syndrome (TLS): TLS is caused by a fast breakdown of cancer cells. TLS can cause you to have kidney failure and the need for dialysis treatment, as well as an abnormal heartbeat. Your healthcare provider may do blood tests to check you for TLS. Call your healthcare provider or get emergency medical help right away if you develop any of these symptoms during treatment with SPRYCEL:
    • nausea
    • vomiting
    • weakness
    • swelling
    • shortness of breath
    • muscle cramps
    • seizures
  • Slowing of growth and development in children: Effects on bone growth and development in children have happened with SPRYCEL and can sometimes be severe. Your healthcare provider will monitor your child’s bone growth and development during treatment with SPRYCEL. Get medical help right away if your child develops bone pain

 

Most common side effects

The most common side effects of SPRYCEL® (dasatinib) in adults and children receiving SPRYCEL alone include:

  • diarrhea
  • headache
  • skin rash
  • shortness of breath
  • tiredness
  • nausea
  • muscle pain

The most common side effects of SPRYCEL in children receiving SPRYCEL with chemotherapy include:

  • swelling, pain, and redness of the lining of your mouth, throat, stomach, and bowel (mucositis)
  • low white blood cell counts with fever
  • fever
  • diarrhea
  • nausea
  • vomiting
  • muscle pain
  • stomach (abdominal) pain
  • cough
  • headache
  • rash
  • tiredness
  • constipation
  • abnormal heart rate
  • high blood pressure (hypertension)
  • swelling
  • infections
  • low blood pressure
  • decreased appetite
  • allergic reactions
  • shortness of breath
  • nosebleed
  • numbness or tingling of your hands and feet
  • feeling confused or disoriented

SPRYCEL may cause fertility problems in males and females. Talk to your healthcare provider if this is a concern for you.

These are not all of the possible side effects of SPRYCEL. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Call your healthcare provider for medical advice about side effects.

You may report side effects to the FDA by calling 1-800-FDA-1088.

How do I store SPRYCEL?

SPRYCEL tablets should be stored at room temperature between 68°F to 77°F
(20°C to 25°C).

Ask your healthcare provider or pharmacist about the right way to throw away outdated or unused SPRYCEL.

Wear latex or nitrile gloves when handling tablets that have accidentally been crushed or broken.

Females who are pregnant should not handle crushed or broken SPRYCEL tablets.

Keep SPRYCEL and all medicines out of the reach of children.

This document has summarized the most important safety information for SPRYCEL. For more in-depth safety information,
please read the Patient Information in the full Prescribing Information.

Information provided in this website is not a substitute for talking to your healthcare provider, who is your best source of information about your disease.

729US1900808-02-01 05/19

All individuals depicted are models used for illustrative purposes only, unless otherwise noted.

Bristol-Myers Squibb

© 2019 Bristol-Myers Squibb Company.

SPRYCEL® and the SPRYCEL logo are trademarks of Bristol-Myers Squibb Company. All other trademarks are the property of their respective owners.

Legal Notice  |  Privacy Policy  |  Site Map  |  Contact Us

729US1900808-01-01 03/19

Close

You are now leaving this Bristol-Myers Squibb site.

This Internet site may provide links or references to other sites.
BMS has no responsibility for the content of such other sites and is not
liable for any damages or injury arising from that content. Any links to
other sites are provided merely as a convenience to the users of this Internet site.

OK

Cancel

Close

You are about to leave SPRYCEL.com, a Bristol-Myers Squibb Company site.
You are being redirected to another Bristol-Myers Squibb Company site.

OK

Cancel

This link is currently not available.
Please check back at a later time.

Close

Close

You are about to leave this Bristol-Myers Squibb Company SPRYCEL.com site.
You are being redirected to the Otsuka America Pharmaceutical, Inc. Corporate website.
Your linking to any other off-site pages or other sites is at your own risk.

OK

Cancel